Multiple sclerosis 2024: Consensus quality indicators for monitoring multiple sclerosis Voigt et al. The Lancet Regional Health – Europe

Executive Summary Multiple sclerosis is an immune-mediated disease of the central nervous system and a leading cause of neurological disability. Considerable progress in imaging techniques and fluid biomarkers have enhanced our understanding of MS, improving diagnostic, prognostic, and treatment monitoring tools. However, understanding the different clinical manifestations, timely diagnosis and treatment success remains a critical unmet need. https://www.thelancet.com/series/multiple-sclerosis-2024?dgcid=hubspot_update_feature_infocusbrainhealth_lanepemultiplesclerosis24&utm_campaign=update-lanepe&utm_medium=email&_hsenc=p2ANqtz--lf7Lfvy6QVrDoMswBrxjtxJvxRj8Hlfggxm8jOX9uYMQpwOrYDASmy05XGFaqr8m-DSmUqfX8hGMywHbHuIf5GQMpKQ&_hsmi=325079447&utm_content=325001241&utm_source=hs_email